Keyphrases
Statins
100%
Hospitalization
100%
Medicare Beneficiaries
100%
Non-adherence
100%
Incident Cancer
100%
Coronary Artery Disease
72%
Beta-blockers
54%
Disease-related
54%
Angiotensin Receptor Blockers
54%
Medication Adherence
54%
Angiotensin-converting Enzyme Inhibitor (ACEi)
54%
Cancer Diagnosis
45%
Medication Classes
36%
Multinomial Logistic Regression
9%
Clinical Practice
9%
Adjusted Odds Ratio
9%
Prostate Cancer
9%
Group Differences
9%
Older Individuals
9%
Mutually Exclusive
9%
Adjusted Analysis
9%
Colorectal Cancer
9%
Breast
9%
Support Services
9%
Medicare Data
9%
SEER-Medicare
9%
Inverse Probability
9%
Medicare Fee-for-service Beneficiaries
9%
General Clinical
9%
Observational Longitudinal Study
9%
Nursing and Health Professions
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Malignant Neoplasm
100%
Medicare
100%
Coronary Artery Disease
100%
Medication Compliance
75%
Angiotensin Receptor Antagonist
75%
Dipeptidyl Carboxypeptidase Inhibitor
75%
Cancer Diagnosis
62%
Drug Therapy
50%
Odds Ratio
12%
Logistic Regression Analysis
12%
Clinical Practice
12%
Prostate Cancer
12%
Longitudinal Analysis
12%
Colorectal Carcinoma
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Coronary Artery Disease
100%
Antihypertensive
100%
Angiotensin Receptor Antagonist
75%
Dipeptidyl Carboxypeptidase Inhibitor
75%
Prostate Cancer
12%
Colorectal Carcinoma
12%